The rapidly aging global population is a major accelerator for the market. According to the World Health Organization, by 2030, one in six people worldwide will be 60 years old or older. The share of the population in this age group will rise from 1 billion in 2020 to 1.4 billion. This demographic shift is contributing to a higher prevalence of pelvic floor disorders, as aging leads to weakened muscles and decreased tissue elasticity, increasing the risk of urinary incontinence.
Therefore, there is a growing demand for therapeutic solutions tailored to the elderly. Pelvic floor electric stimulators offer a non-invasive, user-friendly option for strengthening pelvic muscles and improving quality of life for older adults, creating a larger market for these devices.
The healthcare industry's shift towards non-invasive treatments is driven by patient demand for options with less discomfort and recovery time. Pelvic floor electric stimulators meet this need, offering a pain-free alternative to surgery. Their ease of use and cost-effectiveness are increasing their popularity, boosting market growth and innovation.
Authors:
Mariam Faizullabhoy , Gauri Wani
Frequently Asked Questions (FAQ) :
Global pelvic floor electric stimulator industry was valued at USD 244.1 million in 2023 and is anticipated to register 11.4% CAGR between 2024 and 2032 due to growing aging population, increasing obesity rates, and lifestyle changes
The mobile segment in the market is forecasted to reach USD 415.9 million by 2032, driven by convenience, smartphone connectivity, and increasing demand for non-invasive solutions.
U.S. pelvic floor electric stimulator market is projected to reach USD 245.9 million by 2032 due to the aging population along with the increasing incidence of pelvic floor disorders.
Athena Feminine Technologies, Inc., Axena Health, Inc., Beacmed s.r.l., Chiaro Technology Limited, Everyway Medical Instruments Co., Ltd., InControl Medical., Laborie, Medtronic plc, and Nidd Valley Medical, among others.